Laurion Capital Management LP Insmed Inc Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $659,811 - $894,211	28,173 New	28,173 $873,000
Q4 2020 Feb 12, 2021	SELL	$31.45 - $40.54 $871,165 - $1.12 Million	-27,700 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$26.0 - $34.5 $720,200 - $955,650	27,700 New	27,700 $890,000
Q3 2019 Nov 13, 2019	SELL	$15.49 - $25.78 $5.43 Million - $9.05 Million	-350,865 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$23.0 - $32.19 $8.07 Million - $11.3 Million	350,865 New	350,865 $8.98 Million
Q4 2017 Feb 13, 2018	SELL	$26.43 - $31.78 $845,257 - $1.02 Million	-31,981 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$11.61 - $31.21 $371,299 - $998,127	31,981	31,981 $998,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.